Decision: Glofitamab in the treatment of diffuse large B-cell lymphoma (DLBCL)

Glofitamab: Public Assessment Report (PAR)

PDF, 194 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Glofitamab: Treatment protocol - Information for healthcare professionals

PDF, 315 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Glofitamab: Treatment protocol - Information for patients

PDF, 227 KB, 9 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need aversion of this document in a more accessible format, please email webupdates@mhra.gov.uk.Please tell us what format you need. It will help us if you say what assistive technology you use.

Glofitamab: Information for NHS Medical Director

PDF, 134 KB, 4 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive



View the original news story

Comments

Scroll Back To Top ✎Write Comment

We don't have any comments for this article yet. Why not join in and start a discussion.

Your name:	Your email:
Comments:
Post my comment

GovWire